Doravirine Dose Optimisation in Pregnancy

Recruiting now · Phase 4

Conditions studied: HIV

In brief

A randomised, open label, controlled PK standard of care vs doravirine plus 2 nucleoside reverse transcriptase inhibitors backbone in pregnant women initiating combination antiretroviral therapy in the second trimester of pregnancy.

Key facts

Study ID
NCT05630638
Run by
University of Liverpool
People needed
76
Starts
2023-10-10
Expected to finish
2028-07-01
Last updated by the study team
2026-02-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.